222 Programs
-
SGO Proceedings 2026
Expert Second Opinion: Investigators Provide Perspectives on the Best-Practice Use of Immunotherapy for Endometrial Cancer
-
-
F
-
M
-
R
-
F
-
-
Oncology Today
Optimal Use of PARP Inhibitors for Patients with Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer
-
-
W
-
W
-
-
W
-
W
-
-
Oncology Today with Dr Neil Love
Optimizing Biomarker Assessment and Related Treatment Decision-Making for Patients with HR-Positive Metastatic Breast Cancer
-
-
S
-
S
-
-
S
-
S
-
-
Year in Review
Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Oral SERDs for Breast Cancer
-
-
A
-
E
-
A
-
-
A
-
E
-
A
+1 more module
-